EcoSynthetix Inc. (T:ECO)
Business Focus: Specialty Chemicals
| Sector: Basic Materials | Industry: Specialty Chemicals |
| See Regulatory Filings on SEDAR | |
| Company Contact | |
| Address: | 3365 Mainway BURLINGTON ON L7M 1A6 |
| Tel: | 1-416-815-0700 |
| Website: | ecosynthetix.com |
| IR: | See website |
| Key People | ||
| John E. Barker Chairman of the Board | Jeffrey Douglas MacDonald Chief Executive Officer | Robert Haire Chief Financial Officer, Corporate Secretary |
| Steven Bloembergen Executive Vice President - Technology | Edward van Egdom Senior Vice President - Market Realization and Product Manufacturing | |
| Business Overview |
| EcoSynthetix Inc. (EcoSynthetix) is a renewable chemicals company. The Company is engaged in the development of bio-based technologies as replacement solutions for synthetic, petrochemical-based adhesives and other related products in the United States, Europe, Middle East and Africa (EMEA), and Asia Pacific. Bio-based materials are used as inputs in industrial manufacturing for a range of end products. The Company operates through EcoSphere biolatex binders segment. EcoSphere biolatex binders is used by manufacturers within the coated paper and paperboard industry. It offers over two bio- based technology platforms that support application across industries, a biopolymer nanosphere technology that has scaled and validated, and a bio-based sugar macromer technology. The Company's two bio-based technology platforms has generated approximately four product families, namely EcoSphere biopolymers, EcoMer biomonomers, EcoStix bio-based pressure sensitive adhesives and DuraBind bioresins. |
| Financial Overview |
| For the three months ended 31 March 2017, Ecosynthetix Inc revenues increased 22% to $3.6M. Net loss decreased 20% to $1.9M. Revenues reflect EMEA segment increase from $321K to $743K, America segment increase of 15% to $2M. Lower net loss reflects Provision for termination benefits decrease from $200K (expense) to $0K, Selling, general and admin decrease of 5% to $1.4M (expense). |
| Employees: | 29 as of May 29, 2011 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $105.41M as of Mar 31, 2017 |
| Annual revenue (TTM): | $17.59M as of Mar 31, 2017 |
| EBITDA (TTM): | -$9.71M as of Mar 31, 2017 |
| Net annual income (TTM): | -$11.17M as of Mar 31, 2017 |
| Free cash flow (TTM): | -$11.42M as of Mar 31, 2017 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 57,434,996 as of May 16, 2017 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Company fundamental and
price data sourced from © Thomson Reuters Limited. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent
of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for
any actions taken in reliance on such content. 'Thomson Reuters' and the Thomson Reuters logo are trademarks of
Thomson Reuters and its affiliated companies.
Interactive technical study charts by TradingView. Copyright © 2017 INK Research Corp. All rights reserved.